Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies

Category Primary study
JournalJournal of Clinical Oncology
Year 2014
This article has no abstract
Epistemonikos ID: 1d1a70183bcb4b8c4add86da8b1d67e993ee046c
First added on: Feb 06, 2025